Related by context. All words. (Click for frequent words.) 75 estimated glomerular filtration 74 glomerular filtration rate 73 estimated GFR 72 serum creatinine 70 creatinine 68 creatinine levels 67 serum creatinine levels 67 ng mL 67 creatinine clearance 67 LVEF 67 HbA1c levels 66 PSADT 66 microalbuminuria 66 PSA nadir 66 serum potassium 66 mL/min/#.# m 2 66 GFR 66 HbA 1c 66 biochemical recurrence 66 Hb A1C 66 cystatin C 66 proteinuria 65 troponin T 65 systolic dysfunction 65 specific antigen PSA 65 leukocyte count 65 serum phosphate 65 albumin excretion 65 ng dL 65 pg mL 64 thyroglobulin 64 EDSS score 64 CrCl 64 urinary albumin 64 hemoglobin A1c levels 64 ejection fractions 64 NT proBNP 64 albuminuria 64 serum PSA 64 glycated hemoglobin levels 64 HbA1c 64 glycated hemoglobin 64 creatinine ratio 64 #.#ng/ml 64 serum calcium 63 HOMA IR 63 intima media thickness 63 SCr 63 glycated hemoglobin HbA1c 63 glomerular filtration 63 mg dL 63 lactate dehydrogenase LDH 63 carotid IMT 63 PSA velocity 63 pCR 63 cTnT levels 63 hsCRP 63 alanine aminotransferase ALT 63 hemoglobin A1c 62 nonfasting triglyceride levels 62 apnea hypopnea index 62 macroalbuminuria 62 pmol L 62 platelet reactivity 62 Lp PLA2 62 thyroid stimulating hormone 62 nondiabetic patients 62 renal function 62 mEq L 62 cTnT 62 baseline HbA1c 62 A1C levels 62 HbA 1c levels 62 urine NGAL 62 SUVmax 62 CK MB 62 thyrotropin levels 62 serum sodium 62 ejection fraction 62 hemoglobin A1c HbA1c 62 antigen PSA levels 61 multivariable analysis 61 cTnI 61 A1c levels 61 serum lipid levels 61 nmol L 61 hydroxyvitamin D levels 61 cardiovascular mortality 61 Kaplan Meier analysis 61 glycosylated hemoglobin HbA1c 61 serum prostate 61 serum concentrations 61 tHcy 61 hip BMD 61 iPTH 61 serum phosphorus 61 serum ALT 61 nonfatal MI 61 aspartate aminotransferase AST 61 serum estradiol 61 μmol L 61 pg ml 61 hepatorenal syndrome 61 intact parathyroid hormone 61 hemoglobin concentrations 61 serum HBV DNA 61 serum uric acid 61 urinary albumin excretion 61 glycosylated hemoglobin 61 preserved ejection fraction 61 mm Hg systolic 61 serum calcium levels 61 mmol L 61 hydroxyvitamin D 61 fasting glucose 61 adiponectin concentrations 61 d dimer 61 sUA 61 Hb levels 61 postoperative mortality 61 μg dL 61 definite stent thrombosis 61 alanine aminotransferase 60 HbA1C 60 mIU L 60 hemoglobin concentration 60 preoperative PSA 60 antihypertensive medications 60 cardiac troponin T 60 chest radiographs 60 Prostate Specific Antigen PSA 60 prostate specific antigen 60 antibody titer 60 mmol l 60 elevated LDH 60 μg L 60 mL min 60 coronary revascularization 60 D dimer 60 aminotransferases 60 serum testosterone 60 fasting plasma glucose 60 fasting insulin 60 highest tertile 60 hs CRP 60 serum glucose 60 postintervention 60 hemoglobin A1C 60 Lp PLA 2 60 DAS# [002] 60 elevated LDL cholesterol 60 advanced neoplasia 60 HCV RNA 60 colorectal adenoma 60 lumbar spine BMD 60 statistical significance p 60 MDRD equation 60 #mmHg [001] 60 NIHSS 60 left ventricular systolic 60 subclinical hypothyroidism 60 hemoglobin Hb 60 carotid intima media 60 troponins 60 microalbumin 60 neutrophil counts 60 urine albumin 60 advanced adenomas 60 calculated creatinine clearance 60 systolic pressure 60 -#.# log# 60 NSTE ACS 60 F FDG PET 60 fasting glucose levels 60 Prehypertension 59 serum albumin 59 MetS 59 systolic BP 59 prostate cancer CaP 59 systolic blood pressure 59 univariate 59 nondiabetics 59 ng ml 59 g dL 59 mm Hg 59 beta blocker therapy 59 univariate analysis 59 OGTT 59 CHD mortality 59 Response Evaluation Criteria 59 NIHSS score 59 alteplase 59 urate levels 59 FEV1 59 NGAL 59 MMSE score 59 #mg/dL [001] 59 p = #.# [003] 59 FDG PET 59 mmol L. 59 atheroma volume 59 serum phosphate levels 59 CD4 counts 59 undetectable HBV DNA 59 serum urate 59 HIV RNA 59 lactate dehydrogenase 59 % CI #.#-#.# [006] 59 IPSS 59 PCa 59 LV dysfunction 59 hsCRP levels 59 baseline A1C 59 elevated CRP 59 lipid lowering therapy 59 aminotransferase levels 59 Ejection Fraction 59 irbesartan 59 echocardiographic parameters 59 serum aminotransferase levels 59 urinary protein 59 logistic regression analysis 59 serum testosterone levels 59 mmHg diastolic 59 hypogonadal 59 systolic 59 multivariate Cox 59 echocardiographic 59 NHANES III 59 asymptomatic carotid stenosis 59 oral antidiabetic medication 59 CVD mortality 59 nonfasting triglycerides 59 albumin creatinine ratio 59 Crohn Disease Activity 58 oral glucose tolerance 58 thyroid stimulating hormone TSH 58 baseline FEV 58 QTcF 58 HER2 expression 58 left ventricular ejection 58 lowest tertile 58 CsA 58 CDAI score 58 recurrent VTE 58 adenoma 58 serum GGT 58 binary restenosis 58 periprocedural 58 lymphocytosis 58 HGPIN 58 renal dysfunction 58 fasting blood glucose 58 β blockers 58 lymphocyte counts 58 alkaline phosphatase 58 arterial oxygen saturation 58 GnRH agonist 58 serum HCV RNA 58 prospectively defined 58 advanced adenoma 58 mL/min/#.# m2 58 confidence intervals CIs 58 insulin detemir 58 kidney allograft 58 coronary stenosis 58 mU L 58 clinically insignificant 58 CD4 cell 58 diastolic pressure 58 liver histology 58 HBeAg seroconversion 58 antigen PSA 58 MMSE scores 58 p = .# [002] 58 serum ferritin 58 timepoint 58 prognostic variables 58 Unified Parkinson Disease 58 PCWP 58 HAQ DI 58 endometrial thickness 58 T2DM 58 clinically localized prostate 58 poor metabolizers 58 albumin excretion rate 58 kidney function 58 serum phosphorous 58 mmHg 58 #.#/#.# mmHg [001] 58 serum clusterin levels 58 natriuretic peptides 58 mRNA expression 58 tertiles 58 homocysteine concentrations 58 Index CDAI 58 pT3 58 pulmonary capillary wedge 58 mg dl 58 HIV HCV coinfected 58 virologic response 58 MDRD 58 prostate specific 58 hypertensives 58 postoperative complication 58 serum IGF 58 mmHg systolic 58 telomere lengths 58 left ventricular LV 58 mm Hg diastolic 58 fasting triglyceride levels 58 reinfarction 58 nonobstructive CAD 58 thickness CIMT 58 preintervention 58 serum urate levels 58 biochemical relapse 58 atherogenic dyslipidemia 58 #mmHg [002] 58 left ventricular dysfunction 58 #/#mmHg 58 baseline serum creatinine 58 MADRS score 58 elevated ALT 58 NATRECOR R 58 corticosteroid dose 58 ng dl 58 posttransplant 58 subclinical hyperthyroidism 58 retinal thickness 57 per deciliter mg 57 transferrin saturation 57 perioperative mortality 57 Cystatin C 57 breast carcinoma 57 serum PTH 57 HbA1C levels 57 distant metastases 57 preoperative chemotherapy 57 subclinical atherosclerosis 57 normotensive 57 DAS# scores 57 tertile 57 transaminase levels 57 neurocognitive function 57 UACR 57 Baseline characteristics 57 coronary artery calcium 57 XIENCE V PROMUS Stent 57 pretest probability 57 nonresponders 57 IQR 57 candesartan 57 A1c 57 serum bilirubin 57 Serum creatinine 57 HBV DNA 57 mammographic density 57 euthyroid 57 MELD score 57 radical nephrectomy 57 nonobese 57 serum triglycerides 57 odds ratios ORs 57 thiazide diuretics 57 urinary excretion 57 IGFBP 57 metabolic parameters 57 moderate renal impairment 57 PaO 2 57 NYHA functional class 57 BENICAR HCT 57 elevated homocysteine 57 rs# [002] 57 HbA 1C 57 myocardial viability 57 distant metastasis 57 infarct size 57 lipid lowering drugs 57 elevated uric acid 57 plasma glucose levels 57 Glomerular filtration rate 57 BENICAR 57 Fonarow 57 tumor recurrence 57 radical cystectomy 57 mg/m2 dose 57 detectable HCV RNA 57 erythrocyte sedimentation rate 57 elevated creatinine 57 Secondary efficacy endpoints 57 P = .# 57 Expanded Disability Status 57 multivariable logistic regression 57 serum sodium levels 57 univariate analyzes 57 serum TSH 57 atypical ductal hyperplasia 57 myocardial infarction stroke 57 #ng/ml 57 multivariable adjusted 57 homocysteine levels 57 apolipoprotein B 57 impaired fasting glucose 57 International Normalized Ratio 57 Recurrence Score 57 CDAI 57 glycoprotein IIb IIIa inhibitors 57 Thrombolysis 57 DAPT 57 diastolic BP 57 ALLHAT 57 multivariate analyzes 57 fosamprenavir 57 baseline LDH 57 microalbumin test 57 eplerenone 57 preoperatively 57 severe renal impairment 57 cardiac troponin 57 glycemia 57 CD4 + cell 57 glargine 57 plasma creatinine 57 Hazard Ratio HR 57 ANOVA 57 EpCAM expression 57 KRAS mutations 56 State Examination MMSE 56 retrospective cohort 56 nmol l 56 C reactive protein 56 multiple logistic regression 56 symptomatic intracerebral hemorrhage 56 plasma homocysteine 56 QTc 56 plasma folate 56 immunohistochemical staining 56 isolated systolic hypertension 56 TEAEs 56 nmol liter 56 g dl 56 RECIST Response Evaluation Criteria 56 lymph node metastasis 56 myocardial infarction MI 56 Subgroup analyzes 56 Homocysteine levels 56 noncardiac 56 cardiorespiratory fitness 56 symptomatic VTE 56 cerebral perfusion 56 inflammatory biomarkers 56 coronary artery calcification 56 overt hypothyroidism 56 ug kg 56 microarray experiments 56 metabolite concentrations 56 aldosterone 56 residual platelet reactivity 56 Prostate Specific Antigen 56 K ras mutations 56 neoadjuvant chemotherapy 56 sensitivity specificity 56 plasma glucose 56 Index CDAI score 56 corrected QT interval 56 pelvic lymphadenectomy 56 exhaled nitric oxide 56 serum CRP 56 C Reactive Protein 56 log# copies mL 56 serum selenium 56 cerebral oxygenation 56 hemodynamic parameters 56 CIN3 56 fraction LVEF 56 TURBT 56 creatinine clearance CrCl 56 histologically 56 perioperative complications 56 coronary calcification 56 cART 56 fetuin 56 ADCS ADL 56 diastolic hypertension 56 ximelagatran 56 systolic hypertension 56 plasma leptin 56 tumor histology 56 treat NNT 56 resected pancreatic cancer 56 insulin glargine 56 intraobserver 56 liver transplant recipients 56 inotropic 56 x ULN 56 HSCT 56 angiotensin converting enzyme 56 prespecified 56 adiponectin levels 56 fasting triglycerides 56 virologic failure 56 lymph node metastases 56 nonfatal myocardial infarction 56 femoral neck BMD 56 ACR Pedi 56 diastolic blood pressures 56 inhibin B 56 protein excretion 56 % Confidence Interval 56 LDL C 56 postprocedure 56 plasma renin activity 56 #.#mmol L [001] 56 lipid lowering medications 56 mean baseline HbA1c 56 hypogonadal men 56 antihypertensive therapy 56 QRS duration 56 colorectal carcinoma 56 tolvaptan 56 recurrent ischemia 56 tirofiban 56 thrombolytic therapy 56 multivariate logistic regression 56 AST ALT 56 CK # plasma concentrations 56 Acute renal failure 56 plasma triglycerides 56 EDSS scores 56 urine cytology 56 ml min 56 serum vitamin D 56 D Dimer 56 Solid Tumors RECIST 56 IFN α 56 cystatin 56 spirometric 56 NMIBC 56 graft occlusion 56 interquartile range 56 intravenous diuretics 56 Rectal cancer 56 serum lactate 56 nondiabetic 56 prehypertensive 56 initiating HAART 56 dapagliflozin plus 56 carotid stenosis 56 plasma pharmacokinetics 56 adenoma recurrence 56 ABCB1 56 IU mL 56 Hb A1c 56 triacylglycerol 56 peptide BNP 56 RBP4 56 hepatocellular carcinomas 56 index BMI 56 hematological parameters 56 titrated glipizide 56 ejection fraction EF 56 colorectal neoplasia 56 carotid artery thickness 56 endoscopic remission 56 immunostaining 56 OPCAB 56 arterial stiffness 56 NATRECOR ® 56 #.#mmol l [002] 56 elevated serum creatinine 56 eosinophil count 56 soluble CD# ligand 56 peak VO2 56 plasma uric acid 56 median PFS 56 Glomerular Filtration Rate 55 crossclamp 55 umol L 55 arterial thickening 55 dobutamine 55 elevated triglyceride levels 55 intracranial hemorrhage ICH 55 revascularization procedures 55 complete cytogenetic response 55 BMI ≥ 55 LV hypertrophy 55 paricalcitol 55 mIU ml 55 underwent surgical resection 55 composite endpoint 55 procalcitonin 55 pulmonary arterial 55 prostate carcinoma 55 NPH insulin 55 ischemic cardiomyopathy 55 vessel occlusion 55 undergoing coronary artery 55 Score IPSS 55 hypertensive patients 55 lymphocyte count 55 autonomic dysfunction 55 skin sterol 55 diabetes mellitus DM 55 overt nephropathy 55 SHBG levels 55 repeat revascularization 55 exhaled NO 55 MELD scores 55 CI #.#-#.# [001] 55 LV ejection fraction 55 HCCs 55 angiotensin receptor blockers ARBs 55 serum thyroglobulin 55 Prostate specific antigen 55 posttreatment 55 upper endoscopy 55 #mg/dL [002] 55 sFlt 1 55 histopathologic 55 renal cell carcinomas 55 confidence interval CI 55 ATACAND 55 angiographic outcomes 55 FDG PET scans 55 NYHA class 55 fondaparinux 55 nanograms per 55 EBRT 55 RECIST criteria 55 annualized relapse 55 renal tumors 55 risk stratification 55 atypical hyperplasia 55 HER2 overexpression 55 nondepressed 55 aspartate aminotransferase 55 CHADS2 55 myeloperoxidase 55 undergoing coronary angiography 55 renal impairment 55 platelet counts 55 statin therapy 55 CTEPH 55 N telopeptide 55 serum lipid 55 Skin sterol 55 death reinfarction 55 plasma renin 55 IDDM 55 sunitinib 55 urolithiasis 55 NIH CPSI 55 androgen deprivation 55 Pearson correlation coefficient 55 % CI #.#-#.# [001] 55 pT2 55 Scale EDSS score 55 mg kg dose 55 recurrent venous thromboembolism 55 ICD implantation 55 oral anticoagulation 55 lipoprotein levels 55 bezafibrate 55 statistically significant p = 55 periprocedural MI 55 #.#mmol L [002] 55 evaluable subjects 55 Viral load 55 sustained virologic response 55 familial AF 55 PCA3 scores 55 density lipoprotein cholesterol 55 thromboembolism 55 cystectomy 55 statistically significant p 55 SLN biopsy 55 pancreatic adenocarcinoma 55 airflow obstruction 55 baseline FEV1 55 lipid levels 55 mineral density 55 intravesical therapy 55 interobserver reliability 55 fasting serum 55 carcinoembryonic antigen 55 abdominal adiposity 55 ipsilateral stroke 55 Kaplan Meier 55 Diastolic 55 abciximab 55 flexible sigmoidoscopy 55 prospective observational cohort 55 undergone radical prostatectomy 55 lanthanum carbonate 55 System IPSS 55 concomitant medications 55 urinary calcium 55 loop diuretics 55 R0 resection 55 ASCUS 55 fructosamine 55 isoprostane 55 EBUS FNA 55 sirolimus stent 55 vasopressor 55 #.#mg/dL 55 myocardial infarctions 55 PASI scores 55 urinary oxalate 55 mg d 55 SGRQ 55 mmol 55 acute STEMI 55 viral load 55 Ambulatory Blood Pressure 55 Kidney Disease Outcomes 55 GnRH agonists 55 μg liter 55 macrovascular events 55 creatine kinase 55 CIN2 + 55 renal cysts 55 Insulin sensitivity 55 p = #.# [002] 55 HBeAg 55 prehypertension 55 adrenalectomy 55 Tumor shrinkage 55 undetectable HCV RNA 55 sinus rhythm 55 ≥ 55 hemodialysis patients 55 myocardial ischemia 55 ARB telmisartan 55 covariates 55 nomogram 55 triglyceride concentration 55 F2 isoprostanes 55 Platelet counts 55 angiographically 55 carotid artery intima media 55 epithelial ovarian cancer 55 intraocular pressure IOP 55 sustained virological response 55 serum IgG 55 meta regression 55 platelet aggregation 55 folate intake 54 CCyR 54 T1a 54 mean baseline A1C 54 fasting plasma glucose FPG 54 reticulocytes 54 multivariable Cox 54 nonvertebral fractures 54 hepatectomy 54 STRIDE PD 54 tPSA 54 abnormal cytology 54 nesiritide 54 catheter angiography 54 postdischarge 54 Fasting glucose 54 -#.# mg dL [002] 54 diastolic blood pressure 54 Bonferroni correction 54 OADs 54 oxygen saturations 54 Albuminuria 54 Doppler sonography 54 arterial thromboembolic events 54 A1C 54 neoadjuvant therapy 54 HBV DNA levels 54 coronary angiography 54 left ventricular hypertrophy 54 virological response 54 clinico pathological 54 darbepoetin alpha 54 serum cortisol 54 target vessel revascularization 54 activated partial thromboplastin 54 morphologic 54 abacavir lamivudine 54 uric acid levels 54 Hemoglobin A1c 54 placebo fluoxetine 54 genotypic resistance 54 #mg/day [001] 54 Score DAS# 54 certolizumab 54 polypoid lesions 54 nonfasting 54 ADAS Cog 54 intravascular volume 54 Framingham Risk Score 54 neoadjuvant 54 Pharmacokinetic parameters 54 digital rectal examination 54 multivessel disease 54 nonmetastatic 54 colorectal liver metastases 54 serum folate concentrations 54 subgroup analyzes 54 dysglycemia 54 Inhibin B 54 sarcosine 54 renal insufficiency 54 comorbid conditions 54 coronary calcium 54 thyrotropin 54 relapsed MM 54 Ki# 54 diastolic heart 54 tHcy concentrations 54 MACCE 54 unfractionated heparin UFH 54 imatinib therapy 54 total cholesterol LDL 54 cilostazol 54 microbleeds 54 Kruskal Wallis test 54 liver biopsies 54 plasma concentrations 54 leukocytosis 54 preserved systolic 54 8 OHdG 54 macular thickness 54 epoetin alfa 54 Hb 54 Breslow thickness 54 stone formers 54 pancreatic resection 54 lymph node involvement 54 HRQL 54 QTc prolongation 54 ml kg 54 anti JCV antibodies 54 colorectal neoplasms 54 triglyceride levels 54 dalteparin 54 cells mcL 54 Myelosuppression 54 DEXA scan 54 triacylglycerol concentrations 54 systolic function 54 left ventricular diastolic 54 Systolic 54 platelet activation 54 prospectively randomized 54 SLNB 54 pressure monitoring ABPM 54 carotid plaque 54 undetectable viral load 54 % CI #.#-#.# [004] 54 foveal thickness 54 BLLs 54 oral hypoglycemic agents 54 TRUS 54 Subgroup analysis 54 variance ANOVA 54 conditional logistic regression 54 nephrectomy 54 FDG PET imaging 54 Renal dysfunction 54 patients undergoing CABG 54 immunoreactivity 54 bladder carcinoma 54 eptifibatide 54 Cmax 54 LVSD 54 timepoints 54 radical prostatectomy RP 54 LHRH agonists 54 basal cell nevus syndrome 54 Lymph node 54 International Prostate Symptom 54 oocytes retrieved 54 T2D 54 cytologic 54 serum parathyroid hormone 54 Proteinuria 54 carotid endarterectomy 54 hemoglobin hematocrit 54 S#A# [002] 54 Scale EDSS 54 randomized controlled trials RCTs 54 specific antigen 54 Diastolic pressure 54 Heavy menstrual bleeding 54 KDOQI 54 elevated troponin 54 subtrochanteric 54 abdominal circumference 54 atherothrombotic disease 54 RBC folate 54 KRAS mutation 54 serum leptin 54 secondary efficacy endpoint 54 hematopoietic cancers 54 glomerular 54 mycophenolate mofetil 54 situ LCIS 54 logistic regression models 54 plasma cortisol 54 lipid lowering agents 54 flutamide 54 immunosuppressive regimen 54 troponin 54 urinary sodium excretion 54 adiponectin 54 unfractionated heparin 54 mU liter 54 non fasting triglycerides 54 TOP2A 54 baseline CD4 54 K DOQI 54 adenoma detection 54 cerebrovascular events 54 severe exacerbations 54 oncologic outcomes 54 BMD measurements 54 elevated blood glucose 54 disease progression 54 serum potassium levels 54 lipoprotein 54 lymphadenectomy 54 leptin concentrations 54 HBsAg 54 transrectal ultrasound guided 54 VT VF 54 Ishak fibrosis score 54 Endothelial function 54 IIIa inhibitor 54 FDG uptake 54 nonfatal myocardial infarction MI 54 TT genotype 54 renal allograft 54 white matter hyperintensities 54 Framingham Offspring Study 54 HDL C 54 eculizumab therapy 54 urinary iodine 54 morphometric vertebral fractures 54 APTIVUS r 54 chlorthalidone 54 6MWD 54 hypopneas 54 myocardial necrosis 54 IV bisphosphonates 54 Y BOCS 54 ADPKD 54 neurodevelopmental impairment 54 cardiovascular hospitalizations 54 esophagectomy 54 histologically confirmed 54 urinary cortisol 54 intravascular ultrasonography 54 prospectively stratified 54 Brief Psychiatric 54 hypoperfusion 54 glulisine 54 lung function 54 allopurinol 54 Hgb 54 inflammatory markers 54 HER2 amplification 54 glycosylated hemoglobin levels 54 adenomatous 54 serum homocysteine 54 curative resection 54 bioavailable testosterone 53 noninferiority 53 Psoriasis Area 53 Hcy 53 NNT = 53 hours postdose 53 ventricular mass 53 nicardipine 53 hematuria 53 CI -#.# 53 fluvastatin 53 peginterferon alfa 2a 53 ischemic lesions 53 diastolic pressures 53 ETDRS 53 thickness IMT 53 serum phosphorus levels 53 gastric pH 53 Multivariate analysis 53 SERCA2a 53 NNRTI resistance 53 refractory ischemia 53 transthoracic 53 ALT elevation 53 deep venous thromboses 53 conventional coronary angiography 53 PD2i ®